JP2001507687A5 - - Google Patents

Download PDF

Info

Publication number
JP2001507687A5
JP2001507687A5 JP1998528697A JP52869798A JP2001507687A5 JP 2001507687 A5 JP2001507687 A5 JP 2001507687A5 JP 1998528697 A JP1998528697 A JP 1998528697A JP 52869798 A JP52869798 A JP 52869798A JP 2001507687 A5 JP2001507687 A5 JP 2001507687A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1998528697A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001507687A (ja
Filing date
Publication date
Priority claimed from GBGB9626643.2A external-priority patent/GB9626643D0/en
Application filed filed Critical
Publication of JP2001507687A publication Critical patent/JP2001507687A/ja
Publication of JP2001507687A5 publication Critical patent/JP2001507687A5/ja
Ceased legal-status Critical Current

Links

JP52869798A 1996-12-21 1997-12-18 ピロロ〔3,4−d〕ピリミジノン誘導体および医薬としてのその使用 Ceased JP2001507687A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9626643.2A GB9626643D0 (en) 1996-12-21 1996-12-21 Compounds
GB9626643.2 1996-12-21
PCT/SE1997/002157 WO1998028301A1 (en) 1996-12-21 1997-12-18 Pyrrolo[3,4-d]pyrimidinone derivatives and their use as medicaments

Publications (2)

Publication Number Publication Date
JP2001507687A JP2001507687A (ja) 2001-06-12
JP2001507687A5 true JP2001507687A5 (cg-RX-API-DMAC10.html) 2005-08-11

Family

ID=10804862

Family Applications (1)

Application Number Title Priority Date Filing Date
JP52869798A Ceased JP2001507687A (ja) 1996-12-21 1997-12-18 ピロロ〔3,4−d〕ピリミジノン誘導体および医薬としてのその使用

Country Status (23)

Country Link
US (8) US6046204A (cg-RX-API-DMAC10.html)
EP (1) EP0946562B1 (cg-RX-API-DMAC10.html)
JP (1) JP2001507687A (cg-RX-API-DMAC10.html)
KR (1) KR20000069605A (cg-RX-API-DMAC10.html)
CN (1) CN1246119A (cg-RX-API-DMAC10.html)
AT (1) ATE215088T1 (cg-RX-API-DMAC10.html)
AU (1) AU717429B2 (cg-RX-API-DMAC10.html)
BR (1) BR9714063A (cg-RX-API-DMAC10.html)
CA (1) CA2275312A1 (cg-RX-API-DMAC10.html)
CZ (1) CZ289925B6 (cg-RX-API-DMAC10.html)
DE (1) DE69711430T2 (cg-RX-API-DMAC10.html)
EE (1) EE9900315A (cg-RX-API-DMAC10.html)
GB (1) GB9626643D0 (cg-RX-API-DMAC10.html)
HU (1) HUP0002839A3 (cg-RX-API-DMAC10.html)
ID (1) ID21682A (cg-RX-API-DMAC10.html)
IL (1) IL130538A0 (cg-RX-API-DMAC10.html)
IS (1) IS5082A (cg-RX-API-DMAC10.html)
NO (1) NO993027L (cg-RX-API-DMAC10.html)
NZ (1) NZ336124A (cg-RX-API-DMAC10.html)
PL (1) PL334228A1 (cg-RX-API-DMAC10.html)
SK (1) SK76699A3 (cg-RX-API-DMAC10.html)
TR (1) TR199901433T2 (cg-RX-API-DMAC10.html)
WO (1) WO1998028301A1 (cg-RX-API-DMAC10.html)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9801399D0 (sv) 1998-04-21 1998-04-21 Astra Pharma Prod Method and apparatus for filling containers
AU2107700A (en) 1999-01-15 2000-08-01 Byk Gulden Lomberg Chemische Fabrik Gmbh Phenanthridine-n-oxides with pde-iv inhibiting activity
EP1147103B1 (en) 1999-01-15 2005-05-04 ALTANA Pharma AG Phenantrhridine-n-oxides with pde-iv inhibiting activity
ATE356810T1 (de) 1999-01-15 2007-04-15 Altana Pharma Ag Polysubstituted 6-phenylphenanthridines mit pde- iv hemmender wirkung
US6361486B1 (en) * 2000-02-29 2002-03-26 Agilent Technologies, Inc. Coaxial-drive centrifuge providing tilt control relative to centrifugal force
US20070105841A1 (en) * 2000-08-14 2007-05-10 Breitenbucher J G Method for treating allergies using substituted pyrazoles
US7589202B2 (en) * 2000-08-14 2009-09-15 Ortho Mcneil Pharmaceutical, Inc. Substituted pyrazoles
TW200407315A (en) * 2002-04-23 2004-05-16 Sankyo Co Pyrimidine derivatives
CA2533534C (en) * 2003-07-24 2013-03-19 Tecomet, Inc. Assembled non-random foams
EP1768662A2 (en) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Small molecule immunopotentiators and assays for their detection
MY140748A (en) 2004-12-06 2010-01-15 Astrazeneca Ab Novel pyrrolo [3,2-d] pyrimidin-4-one derivatives and their use in therapy
DK2024367T3 (da) 2006-05-04 2011-01-03 Pulmagen Therapeutics Inflammation Ltd Tetrahydropyrrolopyrimidindioner og deres anvendelse som inhibitorer af human neutrofil elastase
US8198288B2 (en) 2006-05-04 2012-06-12 Pulmagen Therapeutics (Inflammation) Limited Tetrahydropyrrolopyrimidinediones and their use in therapy
AU2007256633B2 (en) 2006-06-06 2013-09-12 Intra-Cellular Therapies, Inc. Organic compounds
ES2588238T3 (es) 2007-12-06 2016-10-31 Intra-Cellular Therapies, Inc. Derivados de pirazolopirimidin-4,6-diona y su uso como producto farmacéutico
WO2009100403A1 (en) * 2008-02-07 2009-08-13 Neurogen Corporation Substituted aryl pyrimidinones
MX2011005934A (es) 2008-12-06 2011-12-16 Intra Cellular Therapies Inc Compuestos organicos.
BRPI0922700A2 (pt) 2008-12-06 2015-08-11 Intracellular Therapies Inc Compostos orgânicos
AU2009322899A1 (en) 2008-12-06 2010-06-10 Intra-Cellular Therapies, Inc. Organic compounds
EP2464354B1 (en) 2009-08-10 2015-04-01 The Regents of The University of California Pyrimido-pyrrolo-quinoxalinedione inhibitors of cystic fibrosis transmembrane conductance regulator protein and uses therefor
EP2575817A4 (en) 2010-05-31 2014-01-08 Intra Cellular Therapies Inc ORGANIC CONNECTIONS
US9371327B2 (en) 2010-05-31 2016-06-21 Intra-Cellular Therapies, Inc. PDE1 inhibitor compounds
USRE48842E1 (en) 2011-05-27 2021-12-07 The Regents Of The University Of California Pyrimido-pyrrolo-oxazine-dione compound inhibitors of the cystic fibrosis transmembrane conductance regulator protein and uses therefor
US9546175B2 (en) 2014-08-07 2017-01-17 Intra-Cellular Therapies, Inc. Organic compounds
CN108129486B (zh) * 2018-01-25 2020-06-05 华东理工大学 嘧啶酮衍生物及其用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993004047A1 (en) * 1991-08-16 1993-03-04 Merck & Co., Inc. Quinazoline derivatives as inhibitors of hiv reverse transcriptase
GB9424842D0 (en) * 1994-12-09 1995-02-08 British Tech Group Pharmaceutical compositions

Similar Documents

Publication Publication Date Title
JP2001510603A5 (cg-RX-API-DMAC10.html)
JP2001527687A5 (cg-RX-API-DMAC10.html)
JP2001503517A5 (cg-RX-API-DMAC10.html)
JP2000506275A5 (cg-RX-API-DMAC10.html)
JP2001508674A5 (cg-RX-API-DMAC10.html)
JP2001502151A5 (cg-RX-API-DMAC10.html)
JP2000512449A5 (cg-RX-API-DMAC10.html)
JP2000508469A5 (cg-RX-API-DMAC10.html)
JP2000506747A5 (cg-RX-API-DMAC10.html)
JP2000506125A5 (cg-RX-API-DMAC10.html)
JP2000511355A5 (cg-RX-API-DMAC10.html)
JP2000510734A5 (cg-RX-API-DMAC10.html)
JP2000515397A5 (cg-RX-API-DMAC10.html)
JP2000510560A5 (cg-RX-API-DMAC10.html)
JP2000517213A5 (cg-RX-API-DMAC10.html)
JP2000517074A5 (cg-RX-API-DMAC10.html)
JP2001503005A5 (cg-RX-API-DMAC10.html)
JP2001505684A5 (cg-RX-API-DMAC10.html)
JP2000514453A5 (cg-RX-API-DMAC10.html)
JP2001503620A5 (cg-RX-API-DMAC10.html)
JP2000509128A5 (cg-RX-API-DMAC10.html)
JP2001513063A5 (cg-RX-API-DMAC10.html)
JP2001505234A5 (cg-RX-API-DMAC10.html)
JP2001506603A5 (cg-RX-API-DMAC10.html)
JP2000512333A5 (cg-RX-API-DMAC10.html)